As I said, cisplatin is not in the comparator arm. The combination that adds cisplatin has already been shown to be superior (at ASCO) to the gemcitabine/nab-paclitxael combo.
Objective: Trial will be designed to show Cell-in-a-Box® + low-dose ifosfamide can serve as an effective and safe consolidation chemotherapy for patients whose tumors no longer respond to the therapy of Abraxane® + gemcitabine or FOLFIRINOX
Market Data 
Markets 
AI
